Commercial: Bristol-Myers Squibb / FDA / Opdivo | Vanderbilt Television News Archive

Commercial: Bristol-Myers Squibb / FDA / Opdivo #1162394

CNN Evening News for Sunday, Oct 18, 2015
View other clips in this broadcast →

Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws.

For adults with an advanced lung cancer called squamous lung small cell previously treated with platinum based chemotherapy. Is known every day something is. Being. A chance to live long. Witho Opdivo. Opdivo Is the first and only immunotherapy. FDA approved based on a clinical trial demonstrating longer life for these patients. In fact. Opdivo significantly increased the chance of living longer versus chemotherapy. Opdivo is different. It works with your immune system. Opdivo can cause your imm...

Duration:: 00:01:28

Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.

Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:

You may request a loan of this video by registering on our website and placing an order.
You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.

If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.